Latest Breaking News On - Aprea therapeutics company profile - Page 1 : comparemela.com

FY2028 EPS Estimates for Aprea Therapeutics, Inc (NASDAQ:APRE) Cut by Analyst

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Analysts at Wedbush reduced their FY2028 earnings per share estimates for Aprea Therapeutics in a research report issued to clients and investors on Tuesday, May 14th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of $0.77 per share for the year, down from […]

Berndr seizingerAprea therapeutics company profileAprea therapeutics incAprea therapeuticsFree reportAprea therapeuticGet free reportDirector berndAprea therapeutics dailyNasdaq apreEarnings estimates

Aprea Therapeutics, Inc (NASDAQ:APRE) Expected to Post Q1 2025 Earnings of ($1 00) Per Share

Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Stock analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Aprea Therapeutics in a research note issued to investors on Tuesday, March 26th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($1.00) per share for the quarter. Wedbush […]

Berndr seizingerGeode capital managementSecurities exchange commissionRoyal bankAprea therapeutics incMillennium managementVanguard group incAprea therapeutics company profileAprea therapeuticsFree reportAprea therapeuticDirector berndExchange commissionCapital managementGet free reportAprea therapeutics daily

Aprea Therapeutics (NASDAQ:APRE) Shares Down 4 9%

Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report)’s share price traded down 4.9% on Monday . The company traded as low as $3.61 and last traded at $3.69. 2,872 shares traded hands during trading, a decline of 87% from the average session volume of 22,918 shares. The stock had previously closed at $3.88. Analyst Ratings […]

Aprea therapeutics incSio capital managementAprea therapeutics company profileRenaissance technologiesMillennium managementAprea therapeuticsGet free reportStreet groupAprea therapeutics dailyNasdaq apre

Aprea Therapeutics, Inc to Post Q3 2023 Earnings of ($1 04) Per Share, HC Wainwright Forecasts (NASDAQ:APRE)

Aprea Therapeutics, Inc to Post Q3 2023 Earnings of ($1 04) Per Share, HC Wainwright Forecasts (NASDAQ:APRE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sio capital managementAprea therapeutics incMillennium managementCapital managementAprea therapeutics company profileAprea therapeuticsFree reportAprea therapeuticTherapeutics trading downGet free reportStreet groupAprea therapeutics daily

Aprea Therapeutics (APRE) to Release Earnings on Monday

Aprea Therapeutics (NASDAQ:APRE – Get Rating) will be releasing its earnings data on Monday, May 15th. Aprea Therapeutics Stock Performance Shares of APRE stock opened at $3.95 on Friday. The company has a market capitalization of $14.74 million, a price-to-earnings ratio of -0.04 and a beta of 0.96. Aprea Therapeutics has a 52 week low […]

Aprea therapeutics incRenaissance technologiesAprea therapeutics company profileMillennium managementMaxim groupAprea therapeuticsGet ratingStreet groupAprea therapeutics dailyNasdaq apre